UNMIRI provides a precision‑oncology infrastructure that standardizes genomic interpretation and delivers decision‑support tools for health‑tech vendors, biotech medical‑affairs teams, and pathologists. Its platform parses cross‑vendor NGS reports into structured FHIR‑Genomics data and offers a citation‑grounded literature intelligence service with inline‑cited answers, while also supplying variant‑aware trial‑matching and prior‑authorization APIs via public sandboxes.
Funding
Funding not disclosed
Founders
Product
Problem
Oncologists and health‑tech platforms must interpret heterogeneous, vendor‑specific genomic reports and stay current with rapidly evolving oncology literature, trial eligibility criteria, and payer policies. The lack of standardized, citation‑backed data forces manual parsing, introduces errors, and slows decision‑making in precision oncology.
Solution
UNMIRI offers a unified precision‑oncology infrastructure that converts diverse NGS reports into structured, FHIR‑aligned genomics data and provides deterministic, evidence‑based APIs for decision support, trial matching, and prior‑authorization. A live literature intelligence platform delivers citation‑grounded, variant‑aware answers and alerts from PubMed, Europe PMC, and clinical trial registries. All outputs trace back to public sources such as CIViC, ClinVar, ClinicalTrials.gov, openFDA, and CPIC, ensuring auditability and regulatory compliance. The system is built on a HIPAA‑ready, open clinical‑evidence architecture with a Neo4j knowledge graph and deterministic rendering, enabling health‑tech vendors, biotech medical‑affairs teams, and pathologists to integrate reliable oncology intelligence into their workflows.
Target Audience
Primary customers are health‑tech and EHR vendors adding oncology capabilities, biotech medical‑affairs teams needing curated literature and trial insights, and pathologists or oncology clinicians requiring rapid, citation‑backed NGS interpretations.
Features
- Cross‑vendor NGS parser that transforms PDFs and JSON reports from major labs (Foundation Medicine, Tempus, Caris, Guardant, Natera, etc.) into structured FHIR R4 Genomics and mCODE‑compatible output
- Variant‑aware trial‑matching API that returns ranked ClinicalTrials.gov results with structured rationales and exact variant identity
- Genomics‑aware clinical decision‑support API delivering AMP/ASCO/CAP‑tiered recommendations with provenance to CIViC, ClinVar, CPIC, and openFDA
- Prior‑authorization decision engine that provides coverage determinations, policy citations, and missing‑criteria lists for specific payer codes
- Live literature intelligence platform offering citation‑grounded, variant‑specific answers, KOL surfacing, and evidence alerts from PubMed, Europe PMC, and congress sources
- Free web tool for pathologists to upload any NGS report and receive tiered interpretations enriched with therapies, trials, and decision support
- HIPAA‑ready deployment with US‑only data residency, de‑identified LLM inputs, and audit logs for reproducible outputs